Oxford VR launches virtual reality (VR) therapy to combat social anxiety in Hong Kong

June 19, 2019
Digital Transformation More...
by Danielle Bradnan and Nardev Ramanathan
Average importance

VR therapy presents the possibility of substituting a human therapist, especially for psychiatric conditions. This is a boon for a market like Hong Kong, where mental health-related disorders are on the rise, and yet there is a huge shortage of psychiatrists (4.5 psychiatrists per 100,000 people) to meet public health demands.The digital therapeutic comprises six to eight VR sessions over a period of three to six weeks that reproduce common social situations and provide guidance for navigating those situations in real time. This is a good example of a startup identifying a unique market opportunity in Asia and fully leveraging its capabilities to present an innovative solution to address the challenge at hand.  

For the original news article, click here .

Further Reading

Roche Diabetes Care India launches Integrated Diabetes Management Solutions (IDMS), seeking to simplify diabetes management

Case Study | May 10, 2019

Diabetes is one of the most expensive chronic diseases to manage today. In India, diabetes is officially the fastest‑growing disease. There are more than 70 million Type 2 diabetics, and the number is expected to double by 2025. Interestingly, robust clinical intervention plans exists to manage ... Not part of subscription

Using the health spectrum to highlight new business opportunities in a "superaging" demographic at the 2019 Lux Executive Briefing in Tokyo

Analyst Insight | June 11, 2019

There are probably only a few things in the world today that we can say we are certain will happen. Aging is one of them. But with all the news around aging and the somewhat negative spin put on it, it is important to first revisit the concept of aging. Aging is a natural process of life, much like ... Not part of subscription

Roche and Wellthy Therapeutics present evidence of improved diabetes care outcomes when patients engage with a digital therapeutic

News Commentary | June 18, 2019

Roche and Wellthy Therapeutics partnered last year to test self‑management practices for Type 2 diabetes using Roche's Accu‑Chek and Wellthy's digital therapeutic (DTx). The study found that those with the highest engagement with Wellthy's DTx saw the largest reduction in blood sugar levels. The ... To read more, click here.